Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2026-02-10 @ 3:47 AM
Study NCT ID:
NCT06881992
Status:
RECRUITING
Last Update Posted:
2025-10-21
First Post:
2025-03-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Sponsor:
Rezolute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Tumor Hyperinsulinism (Tumor HI) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Doege-Potter Syndrome | View |
| None | Ectopic insulinoma | View |
| None | Extra-pancreatic insulinoma | View |
| None | Fibrosarcoma | View |
| None | HCC | View |
| None | Hyperinsulinemia | View |
| None | Hypoglycemia | View |
| None | Hypoglycemia due to fibrosarcoma | View |
| None | Hypoglycemia due to HCC | View |
| None | Hypoglycemia due to liposarcoma | View |
| None | Hypoglycemia due to tumor/cancer | View |
| None | IGF 2 Insulinoma | View |
| None | IGF 2 mediated non islet cell tumor hypoglycemia | View |
| None | IGF-2 mediated hypoglycemia | View |
| None | IGF-2, Big IGF-2 | View |
| None | IGF-oma, IGF-2-oma, Big IGF-2-oma | View |
| None | Insulinoma | View |
| None | Islet cell tumor (ICT) | View |
| None | Liposarcoma | View |
| None | Neuroendocrine tumor (NET) | View |
| None | NICTH | View |
| None | Non Islet Cell Tumor | View |
| None | Non-islet cell tumor hypoglycemia (NICTH) | View |
| None | Paraneoplastic | View |
| None | Paraneoplastic hypoglycemia | View |
| None | PNET | View |
| None | Pro-insulinoma | View |
| None | Tumor/cancer associated hypoglycemia | View |
| None | Tumor/cancer induced hypoglycemia | View |
| None | Tumor/cancer mediated hypoglycemia | View |
| None | Clinical Trials for: -Insulinoma -proinsulinoma -extrapancreatic insulinoma -non-islet cell tumor … | View |